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In Drosophila, glial cell differentiation requires the expression of glial cells missing (gcm) in multiple neural cell lineages, where gcm acts
as a binary switch for glial vs. neuronal fate. Thus, the primary event controlling gliogenesis in neural progenitors is the transcription of gcm.
In addition, gcm is also required for the differentiation of macrophages, and is expressed in the hemocyte lineage. This dual role of gcm in
glial cell and blood cell development underscores the need for the precise temporal and spatial regulation of gcm transcription. To understand
how gcm transcription is regulated, we have undertaken an analysis of the cis-regulatory DNA elements of gcm using lacZ reporter activity in
transgenic embryos, testing the activity of approximately 35 kilobases of DNA from the gcm locus. We have identified several distinct DNA
regions that promote most of the elements of gcm expression. These include elements for general neural expression, gcm-independent and
gcm-dependent glial-specific expression, as well as early and late hemocyte expression. We show that expression of an abdominal glial-
specific element is dependent on the homeotic gene abdominal-A. Our results indicate that gcm transcription is controlled by a combination
of general and lineage-specific elements, positive autoregulation, and neuronal repression.
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A functional nervous system requires the correct speci-
fication and precise organization of a large number of neural
cell types. A central problem of developmental neurobiol-
ogy is to understand mechanisms by which neural progen-
itor cells give rise to this diversity of cell types. Neural cells
can be classified into two distinct groups, neurons and glia.
One general rule that has emerged from lineage analysis of
neurogenesis is that both neurons and glia are generated
from multipotent neural progenitors or neural stem cells
(e.g., Bossing et al., 1996; Davis and Temple, 1994; Frank
and Sanes, 1991; Schmid et al., 1999; Schmidt et al., 1997;
Stemple and Anderson, 1992; Turner and Cepko, 1987;
Udolph et al., 1993; Williams and Price, 1995). While much
effort has been made to identify such progenitors and0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: bjones@saturn.med.nyu.edu (B.W. Jones).mechanisms controlling their fates, the mechanisms that
control whether neural progenitor cells will adopt glial vs.
neuronal fates are poorly understood.
In vertebrates, neural stem cells respond to multiple cell-
intrinsic, cell-extrinsic and temporal cues that induce glial
cell fates, yet no single developmental pathway leading to
gliogenesis has been discovered (Anderson, 2001). In Dro-
sophila, however, a single gene, glial cells missing (gcm,
also known as glide), is the primary regulator of glial cell
determination. gcm encodes a novel transcription factor that
is transiently expressed in all embryonic glia except for the
midline/mesectoderm-derived glia (Akiyama et al., 1996;
Hosoya et al., 1995; Jones et al., 1995; Schreiber et al., 1997;
Vincent et al., 1996). gcm loss-of-function mutant embryos
lack nearly all lateral glial cells, and presumptive glial cells
are transformed into neurons (Hosoya et al., 1995; Jones et
al., 1995; Vincent et al., 1996). Conversely, when gcm is
ectopically expressed, presumptive neurons are transformed
into glia (Hosoya et al., 1995; Jones et al., 1995). Thus,
within the nervous system, gcm acts as a binary genetic
switch, with Gcm-positive cells becoming glia and Gcm-
negative cells becoming neurons.
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lateral glial cell determination. In addition, the expression
of gcm mRNA and protein closely profiles the initiation of
gliogenesis in the various neural lineages that generate
glia. These observations lead to the conclusion that the
primary event controlling gliogenesis is the transcriptional
regulation of gcm. It also follows that gcm is likely to be
regulated by a combination of factors whose expression is
not restricted to glia.
Glia are derived from neural progenitors that originate
in the ventral neurogenic ectoderm and the peripheral
ectoderm lateral to either side of the midline (Bossing et
al., 1996; Goodman and Doe, 1993; Jan and Jan, 1993;
Schmid et al., 1999; Schmidt et al., 1997). In the PNS,
neural stem cells called sensory organ precursors (SOPs)
undergo a series of cell divisions that generate specific
types of neurons, glia, and other support cells. In the
CNS, two types of progenitors generate glia: glioblasts
(GBs) that give rise to only glial cells, and neuroglio-
blasts (NGBs) that produce mixed glial/neuronal lineages.
All of the neural lineages in the PNS and CNS give rise
to unique and stereotypic patterns of neuronal and glial
progeny.
How each neural stem cell generates stereotypic patterns
of multiple cell types in their lineage is not well understood.
What is known is that neural progenitors express different
combinations of transcription factors depending on their
dorsal–ventral and anterior–posterior position within each
segment, the timing of their delamination from the neuro-
ectoderm and as they generate early-, mid- and late-born
daughter cells (Brody and Odenwald, 2000; Doe et al.,
1998; Goodman and Doe, 1993; Isshiki et al., 2001; Jan and
Jan, 1993; Kambadur et al., 1998; Novotny et al., 2002). In
addition, as neural progenitors divide, they inherit localized
determinants such as Prospero and Numb, and are subject to
signaling from the Notch pathway, which differentiates
sibling cell fates (Doe et al., 1991; Hirata et al., 1995;
Knoblich et al., 1995; Rhyu et al., 1994; Udolph et al.,
2001; Uemura et al., 1989; Umesono et al., 2002; Vaessin et
al., 1991). How all these factors come together to produce
different patterns of glial vs. neuronal progeny is poorly
understood. In the case of glial cells, the resulting readout of
combinations of temporal and spatial cues somehow leads to
the activation of gcm and the initiation of glial cell differ-
entiation in precise and stereotypic patterns in the nervous
system.
In addition to acting as a regulator of glial cell differen-
tiation, gcm, together with its closely related homolog gcm2
(also known as glide2), is required for the proper differen-
tiation of the plasmatocyte/macrophage lineage of blood
cells, or hemocytes, that are derived from the procephalic
mesoderm (Alfonso and Jones, 2002; Bernardoni et al.,
1997; Kammerer and Giangrande, 2001; Lebestky et al.,
2000). Before gcm is activated in glial progenitors, gcm is
expressed in the hemocyte primordium and in hemocyte
precursors where it acts to trigger the maturation of hemo-cytes into macrophages. The ability of gcm to promote either
glial cell differentiation or blood cell differentiation in
different developmental contexts suggests that it cooperates
with other tissues specific factors, which underscores the
need for the precise temporal and spatial regulation of gcm
transcription in the mesoderm and neuroectoderm.
The transcriptional regulation of gcm provides a model
for understanding how diverse genetic inputs are integrated
in different neural lineages to give rise to stereotypic
patterns of glial vs. neuronal progeny, as well as the
differentiation of the hematopoietic lineages. To identify
genetic inputs controlling the transcriptional regulation of
gcm, we have undertaken a systematic analysis of the cis-
regulatory DNA elements of gcm using lacZ reporter
activity in transgenic embryos. Recent studies aimed at
rescuing gcm mutant phenotypes with gcm locus genomic
clones demonstrate that as much as 9 kilobases (kb) of
upstream flanking sequences are required to partially rescue
glial differentiation in most CNS glia cell lineages in the
embryo (Ragone et al., 2003); however, they also suggest
that additional cis-regulatory DNA elements are required for
complete rescue. Here we describe experiments testing the
reporter activity of approximately 35 kilobases of DNA
flanking the gcm transcription unit. We follow by further
dissecting the DNA 9 kb upstream and 3 kb downstream of
gcm, where we have identified several distinct regions that
promote most of the elements of the gcm expression pattern;
these can be further subdivided into general neural expres-
sion elements, gcm-independent and gcm-dependent glial-
specific elements, as well as early and late hemocyte
elements. gcm-independent activity in most CNS glial
lineages lies within the first 5 kb upstream of the gcm
promoter, as reporter expression is still initiated in gcm
mutant embryos. gcm-dependent glial-specific activity lies
further distal to the gcm promoter, where the presence of
Gcm-binding sites implicates an autoregulatory mechanism.
We have also identified a 3V element that drives expression
in a small subset of abdominal and maxillary segment glia
that are derived from a single neural progenitor in each
hemisegment. We show that the expression of this element
in the abdominal region is dependent on the homeotic
selector gene abdominal-A, indicating that anterior–poste-
rior segmental differences in glial progenitor lineages are
under the control of homeotic genes of the Hox complex.
Our results indicate that gcm transcriptional regulation is
controlled by a combination of both general and lineage-
specific elements, positive autoregulation, and active repres-
sion in neurons.Materials and methods
Construction of gcm-lacZ reporter genes
Two different transformation vectors were used to
construct gcm-lacZ reporter genes: pCasPeR-hs43-lacZ
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pCasPeR-gcmp-lacZ (abbreviated gcmp-lacZ). The hs43-
lacZ vector contains the lacZ reporter gene transcribed
from a minimal promoter consisting of the hsp70 TATA
box, deleted at 43, and leader sequences, and has been
used extensively for testing enhancers and tissue-specific
regulatory elements. The gcmp-lacZ vector is a derivative
of pCasPeR-h-gal (Thummel et al., 1988) that contains
424 base pairs (bp) from the gcm promoter region,
including the first 17 amino acid codons of gcm fused
in frame with the lacZ gene. PCR was used to generate
the gcm promoter fragment, which includes the natural
EcoRI site located 368 bp upstream of the ATG, as well
as unique restriction sites (PstI, XbaI, NotI, SacII, and
BamHI). A SmaI site was engineered at amino acid codon
17 and the PCR fragment, cut with XbaI and SmaI, was
cloned into pCasPeR-h-gal at the XbaI and blunted
BamHI sites. As a reference point, we refer to +1 as
the position of the start of the longest published gcm
cDNA (Hosoya et al., 1995, GenBank Accession No. ,
D64040); thus, as well as the endogenous ATG, gcmp-
lacZ includes the 150-bp 5V UTR and 223 bp of flanking
sequence.Fig. 1. Structure of the genomic region at the gcm locus; gcm-reporter constructs.
three other predicted genes, derived from sequences and gene predictions from the
al., 2000). Distal to proximal orientation on chromosome 2 is from left to right. F
represented by three overlapping (blue) lines. Arrowheads indicate that cloned DN
red, with 0 denoting the transcription start site of gcm. Predicted transcripts are rep
gcm2 exons are shown with the shaded part (red) representing coding sequence. Re
XbaI. Ovals represent location of putative Gcm-binding sites (Miller et al., 1998;
transgenic animals are shown below the restriction map, designated by names to t
shown: gcmp-lacZ and hs-43-lacZ. Reporter constructs and expression patterns aThe genomic DNA clones used in this study to
generate reporter constructs (Fig. 1) came from previous-
ly described genomic walks of the region spanning 30B–
30C (Ecc2, Eg14 are from Lane and Kalderon, 1993;
cos3.12.16 is from Jones et al., 1995). The endpoints of
the genomic clones were sequenced to map them pre-
cisely onto the published Drosophila melanogaster ge-
nomic sequence (Adams et al., 2000). Fragments of gcm
region DNA used in gcm-lacZ reporter genes are shown
in Fig. 1. Genomic fragments were cloned into either
hs43-lacZ or gcmp-lacZ with the normal 5V to 3V
orientation with respect to the gcm promoter preserved.
All constructs were introduced into flies by P-element-
mediated transformation.
D. melanogaster stocks and genetics
w1118 and y1w67c23 were used for generating transgenic
lines. The gcm null allele was gcmyP1 (Jones et al., 1995);
the abd-A null allele was abd-AMX1 (Sanchez-Herrero et al.,
1985). All reporter lines crossed into mutant backgrounds
were analyzed in homozygous condition so as to easily
identify misexpression in mutant embryos.Map of the genomic region 30B–30C, showing locations gcm, gcm2, and
Drosophila Genome Project (GenBank Accession No. AE003625; Adams et
rom top to bottom. Genomic DNA clones Ecc2, Eg14, and cos3.12.16 are
A extends beyond the bounds of the map. Distance in kilobases is marked in
resented by rectangles, arrows represent direction of transcription; gcm and
striction map of genomic DNA indicating sites: B = BamHI, E = EcoRI, X =
Ragone et al., 2003). Fragments used for lacZ reporter constructs tested in
he left or right. lacZ vectors that were used to make reporter constructs are
ssociated with them are described in detail in Table 1.
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Horseradish peroxidase (HRP) immunohistochemistry
and embryo dissection were done as previously described
(Patel, 1994). Rabbit anti-h-galactosidase (h-gal) anti-
body (Cappel) was used at 1:10,000 dilution. Mouse
anti-Engrailed/Invected monoclonal antibody 4D9 (Patel
et al., 1989) was used at a 1:5 dilution. Mouse anti-Repo
Monoclonal antibody 8D12 (Alfonso and Jones, 2002)
was used at a 1:5 dilution. Secondary antibodies conju-
gated to HRP (Jackson Immunoresearch) were used at
1:300 dilutions. Secondary antibodies were detected using
HRP/Diaminobenzidine (DAB) reaction. DAB reactions
were enhanced to give a black color by addition of
0.067% NiCl2.Results
gcm expression in the embryo
The expression pattern of gcm in the embryo has been
well described (Alfonso and Jones, 2002; Bernardoni et al.,
1997; Freeman and Doe, 2001; Hosoya et al., 1995; Jones
et al., 1995; Umesono et al., 2002; Vincent et al., 1996).
These studies followed gcm expression by in situ locali-
zation of gcm transcripts, by antisera against Gcm protein,
and by the expression of the more persistent h-gal protein
found in the gcmrA87 enhancer trap embryos that marks
cells that transiently express gcm. We summarize these
data as follows.
gcm transcripts and protein are first detected in the
embryo at stage 5 in an anterior ventral region of the
blastoderm that comprises the hemocyte anlagen. During
gastrulation, these cells invaginate at the end of the ventral
furrow to give rise to the hemocyte primordium. gcm
continues to be expressed in hemocytes as they develop into
macrophages and begin to migrate from the cephalic region
through stage 12, after which gcm expression fades. Persis-
tent expression of h-gal in gcmrA87 enhancer trap embryos
shows that gcm is expressed in all hemocytes of the plasma-
tocyte/macrophage lineage.
gcm is first detected in glial progenitors at early stage 10
in the longitudinal glioblast or glial precursor (GP) that
gives rise to the longitudinal glia (Jacobs et al., 1989; Jones
et al., 1995; Hosoya et al., 1995; Schmid et al., 1999;
Schmidt et al., 1997). Shortly thereafter, gcm is detected in
the neural precursor 6–4; in thoracic segments this precur-
sor generates both glia and neurons, and is called NGB 6–
4T, whereas in abdominal segments it produces only glia
and is called GB 6–4A (Akiyama-Oda et al., 1999; Ber-
nardoni et al., 1999; Freeman and Doe, 2001; Hosoya et al.,
1995; Schmid et al., 1999; Schmidt et al., 1997). From late
stage 10 through stage 13, gcm is expressed in the glial
progeny of all other neural precursors that generate mixed
lineages of glia and neurons (except for the midline glia);these include thoracic and abdominal NGBs 1–1A, 1–3, 2–
2T, 2–5, 5–6, and 7–4 that produce CNS cell body and
subperineurial glia and the CNS-derived peripheral glia that
ensheath the axons of the PNS nerve tracks. gcm is also
expressed in glial precursors of the head and gnathal seg-
ments. gcm continues to be expressed in all developing
lateral glia as they differentiate through early stage 16, after
which expression fades.
In addition, gcm is expressed in a subset of PNS
lineages derived from sensory organ precursors (SOPs).
In the abdomen, gcm is expressed at stages 12 through 13
in the ligament cells of the of the lateral chordotonal
organs, the glial support cells of the dorsal bipolar
dendrite (dbd) neuron, and the SOP-derived dorsolateral
peripheral glia (dlPG, also known as PG3) that ensheaths
the distal portion of the intersegmental nerve (Sepp et al.,
2000; Umesono et al., 2002). Expression of gcm in the
PNS of the thorax and head has not been well described.
Finally, gcm is transiently expressed in a lateral stripe of
cells in the epidermis of each segment from stages 12 through
15. By position andmorphology this expression is likely to be
in the primordium of the intersegmental apodemes, a single
row of cells in the segmental furrow that serve as attachment
sites for muscles (Campos-Ortega and Hartenstein, 1997).
Expression of h-gal in the intersegmental apodemes of
gcmrA87 enhancer trap embryos supports this conclusion
(Granderath et al., 2000).
Identification of cis-regulatory elements of gcm
To map transcriptional control elements that produce the
gcm expression pattern, we dissected approximately 35 kb of
DNA flanking the gcm transcription unit into fragments,
fused these to lacZ reporter genes, and introduced the gene
fusions into flies via P-element-mediated transformation. We
then assayed the protein expression patterns driven by these
gene fusions in transgenic embryos using anti-h-gal anti-
bodies.
Many fragments were initially tested using a vector
containing a minimal hsp70 promoter fused to the lacZ
gene (abbreviated hs43-lacZ). Concerned that we may be
missing important expression elements without the endog-
enous gcm promoter, which lacks a TATA box, we also
constructed a vector containing gcm promoter sequences
fused to lacZ (abbreviated gcmp-lacZ). In gcmp-lacZ, the
first 17 amino acid codons of gcm are fused in frame with h-
gal, which includes the endogenous ATG, 5VUTR and 223
base pairs of flanking DNA (see Materials and methods).
We found no significant differences in the expression
patterns of constructs using these two different vectors,
though we consistently observed more robust h-gal expres-
sion with gcmp-lacZ–gcm genomic DNA gene fusions. In
addition, gcmp-lacZ has its own consistent expression
pattern elements (described below).
Fig. 1 depicts a map of approximately 40 kb of DNA
from the gcm region and the fragments used in this study.
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gcm, to CG4389, located 4 kb 3V of gcm. gcm2 encodes a
homolog of gcm that is expressed at very low levels in a
similar pattern to gcm (Alfonso and Jones, 2002; Kammerer
and Giangrande, 2001). CG4389 encodes a long-chain
enoyl-CoA hydratase that is maternally expressed (E.M.
Jolicoeur, unpublished data). Evenly spaced between gcm
and gcm2 are two predicted genes encoding for carboxy-
lesterases, CG4382 and CG3841; Northern analysis indi-
cates that these genes are not expressed at significant levels
in the embryo (B.W. Jones, unpublished data).
In the 28 kb separating gcm and gcm2, there are many
sequences that either match or carry at least one mismatch
from the consensus Gcm binding site (GBS), AT(G/
A)CGGG(T/C). Most of these potential GBS variants can
bind Gcm protein and promote Gcm-dependent transcrip-
tion to some degree in tissue culture, yet they have not been
tested in the organism (Akiyama et al., 1996; Miller et al.,
1998; Ragone et al., 2003; Schreiber et al., 1997, 1998).Table 1
Expression of gcm-lacZ gene fusion constructs shown in Fig. 1
Genomic fragment Reporter vector No. of lines Early embryonic stages (
gcm 0.2 gcmp-lacZ 8 st. 8,9: hemocyte primor
(weak, 4 out of 8 lines)
gcm 1.4 gcmp-lacZ 4 st. 8,9: hemocyte primor
gcm 4.9 hs43-lacZ 7 st. 8,9: hemocyte primor
gcm 4.9 gcmp-lacZ 6 st. 6–9: hemocyte primo
gcm 7.4/4.4 hs43-lacZ 8 –
gcm 7.4/4.4 gcmp-lacZ 6 st. 6–9: hemocyte primo
gcm 8.9/4.4 hs43-lacZ 8 –
gcm 8.9/4.4 gcmp-lacZ 3 st. 6–9: hemocyte primo
gcm 10/7.4 gcmp-lacZ 3 st. 8,9: hemocyte primor
gcm 11.5/10 gcmp-lacZ 4 st. 8,9: hemocyte primor
gcm 18/11.5 gcmp-lacZ 7 st. 8,9: hemocyte primor
gcm 20/14 gcmp-lacZ 6 st. 8,9: hemocyte primor
gcm 24/20 gcmp-lacZ 4 st. 8,9: hemocyte primor
gcm 29/24 gcmp-lacZ 3 st. 8,9: hemocyte primor
gcm +1.7/+5.6 hs43-lacZ 5 –
gcm +1.7/+5.6 gcmp-lacZ 3 st. 8,9: hemocyte primor
gcm +1.7/+2.6 gcmp-lacZ 2 st. 8,9: hemocyte primor
gcm +1.7/+4.5 hs43-lacZ 5 –
gcm +2.6/+4.5 hs43-lacZ 10 –
gcm +3.5/+4.5 hs43-lacZ 3 –
gcm +3.8/+4.5 hs43-lacZ 6 –
gcm +2.6/+3.5 hs43-lacZ 8 –
For each transgenic line, the vector used, the number of lines analyzed, and a brief
listed. Expression patterns that are associated with gcmp-lacZ vector are denotedGBSs in the 5V region of gcm have been presented as
evidence for autoregulation (Miller et al., 1998). In the 8.9
kb 5Vregion, between gcm and CG3841, we find three GBSs
that are a perfect match to consensus, and up to six more
that carry at least one mismatch; three of these mismatched
GBSs have been shown to bind with moderate to high
affinity to Gcm protein (Ragone et al., 2003). A second
cluster of GBSs is near the promoter of gcm2, suggesting
regulation of gcm2 by gcm. We show in Fig. 1 only those
GBSs that are a perfect match, or have been shown to bind
Gcm in vitro.
A summary of the fragment/vector combinations gener-
ated for this study, as well as the number of lines analyzed,
and their expression patterns, is shown in Table 1. Most
fragments from 8.9 to +5.6 kb with respect to the gcm
promoter were tested as gene fusions with both hs43-lacZ
and gcmp-lacZ, yielding similar results. Fragments further
upstream (29 kb to 7.4 kb) were tested only with the
gcmp-lacZ vector.5–9) Late embryonic stages (9–16)
dium st. 9–16: lateral epidermis (weak), CNS (weak)
dium st. 9–16: lateral epidermis (weak), CNS (stronger)
CNS expression strongest at st. 12
dium st. 9–16: lateral epidermal stripe at intersegmental furrow
st. 11–16: CNS-derived glia, dorsal PG
rdium st. 9–16: lateral epidermal stripe at intersegmental furrow
st. 11–16: CNS-derived glia, dorsal PG
st. 9–16: hemocytes, macrophages
st. 11–16: CNS-derived glia, no dorsal PG
rdium st. 9–16 lateral epidermal stripes (weak)
st. 9–16: hemocytes, macrophages
st. 11–16: CNS-derived glia, no dorsal PG
st. 9–16: hemocytes, macrophages
st. 11–16: CNS-derived glia, (no dorsal PG)
rdium st. 9–16 lateral epidermal stripes (weak)
st. 9–16: hemocytes, macrophages
st. 11–16: CNS-derived glia, (no dorsal PG)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
SOP glia: lig., dbd, and dorsal PG (weak, 4 out of 7 lines)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
SOP-derived glia: lig., dbd, and dorsal PG
(weak, 2 out of 6 lines)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
dium (weak) st. 9–16: epidermal stripes—intersegmental apodemes
–
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
st. 11–16: GB6–4A glia (M-CBG, MM-CBG) (weak)
dium (weak) st. 9–16: lateral epidermis (weak), CNS (weak)
st. 11–16: GB6–4A glia (M-CBG, MM-CBG)
st. 11–16: GB6–4A glia (M-CBG, MM-CBG)
st. 11–16: GB6–4A glia (M-CBG, MM-CBG)
st. 11–16: GB6–4A glia (M-CBG, MM-CBG)
–
description of tissues expressing lacZ at early and late embryonic stages are
with italics.
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activity reproducing elements of the gcm expression pat-
tern—in hemocyte progenitors, in CNS derived glial cells
(including NGB derived peripheral glia), and in epidermal
stripes—can be found in the DNA regions immediately
flanking gcm bounded by CG3841 and CG4389, from
8.9 kb to +5.6 kb with respect to the gcm promoter. None
of these elements, however, reproduced expression in SOP-
derived glia, which include the ligament cells of the lateral
chordotonal organs, and the dbd glia. Our survey of frag-
ments of the region further upstream, from CG3841 to gcm2
(8.9 to 29 kb) showed little consistent activity except
that associated with the gcmp-lacZ vector. While we found
two large overlapping fragments that promote weak activity
in SOP-derived glia between 20 and 11.5 kb relative to
the gcm promoter, the weak expression and variability in
these lines do not provide much confidence that they
represent bona fide regulatory elements for the SOP-derived
glia (data not shown).
The only other upstream fragment gene fusion with
reproducible expression is gcm 29/24-gcmp-lacZ,
which has part of the gcm2 gene, including the first 28
amino acid codons, transcription start site, and 3 kb of
flanking DNA with orientation preserved in opposite
direction to the gcmp-lacZ promoter; these lines consis-
tently express h-gal in the lateral epidermal stripes that
become the intersegmental apodemes (data not shown).
Despite the presence of three consensus GBSs, and up to
six more GBSs with one mismatch, we observed no glial
expression in gcm 29/24 embryos.
In the following sections, we describe our results in more
detail, dividing the focus on three regions of gcm flanking
DNA that reproduce most of the expression pattern elements
of gcm: (1)4.9 kb relative to the gcm promoter; (2)8.9 to
4.4 kb; and (3) +1.7 to +5.6 kb.
gcm 4.9 lacZ reporters drive expression in lateral glial
cells, hemocyte primordium, and epidermis
Two separate constructs were analyzed containing sequen-
ces 4.9 kb upstream of gcm. gcm 4.9-hs43-lacZ (with
genomic sequence 4873 to +32) includes start site and part
of the 5VUTR cloned into hs43-lacZ, and gcm 4.9-gcmp-
lacZ (with genomic sequence 4873 to +201) includes the
endogenous promoter and part of the ORF fused to lacZ. Both
constructs drive h-gal expression in near identical patterns,
with gcmp-lacZ transgenes showing slightly earlier and
stronger expression.
A line carrying the gcm 4.9-hs43-lacZ construct is
shown in Figs. 2D–J. h-gal expression in hemocyte
progenitors is detected at stage 8 (stage 6 in gcmp-lacZ
lines), and becomes strongest between stages 9 (Fig. 2D)
and 11, after which it fades. Glial expression of h-gal in
gcm 4.9 embryos is first detected at late stage 10.
Patches of epidermal expression begin at stage 11, and
by stage 13 (Fig. 2G) they resolve into broad stripes,several cell bodies wide, spanning the segmental furrow
in each segment; by contrast, normal gcm expression is
restricted to only a single row of cells in the segmental
furrow of each segment. By stage 13, h-gal is expressed
in nearly all CNS-derived glia cells, including NGB-
derived peripheral glia (Fig. 2G). Both glial expression
and epidermal expression persist through stage 16 (Figs.
2H,J and 3A).
Specific CNS expression of gcm 4.9 lacZ does not require
endogenous gcm activity
Given the presence of two high-affinity GBSs in the gcm
4.9 sequence, it was important to test the expression of
gcm 4.9 reporters in a gcm mutant background. In gcm
mutant embryos that also carry the gcm 4.9 reporter, we
found that h-gal expression is initiated in the CNS, but
instead of glial-specific expression, h-gal is expressed in the
cell bodies of specific neurons (Fig. 3B). In gcm mutant
embryos, CNS glia are transformed into neurons (Hosoya et
al., 1995). We conclude that gcm 4.9 expression is
initiated independent of gcm, in presumptive glial cells that
are transformed into neurons, and that factors that can
initiate gcm expression in most CNS glia must act on the
4.9-kb fragment.
Proximal elements drive pan-neural, weak epidermal, and
early hemocyte expression
We also made constructs that delete distal parts of the
gcm 4.9 fragment. Deleting 3.5 kb of gcm 4.9 gcmp-
lacZ to create gcm 1.4 (Fig. 2A) causes glial-specific
expression to be lost; however, h-gal is now expressed at
significant levels in all CNS cells except for the midline;
this broad CNS expression peaks at stages 12 through 13,
with expression strongest in the lateral CNS (Figs. 2B,C).
gcm 1.4 embryos also show weak epidermal expression,
as well as expression in the hemocyte primordium similar
to gcm 4.9 (data not shown). Finally, our gcmp-lacZ
promoter construct, which contains the endogenous ATG,
5VUTR and 223 base pairs of flanking DNA (gcm 0.2,
Fig. 2A), has very weak broad expression in the nervous
system and epidermis, and weak early hemocyte expres-
sion (data not shown); in addition, most of the constructs
we made using the gcmp-lacZ construct have weak neural,
epidermal, and sometimes stronger early hemocyte expres-
sion (see Table 1).
We conclude that proximal to the gcm promoter are
elements for head mesoderm/hemocyte primordium-spe-
cific expression, as well as weak neural and epidermal
promoting elements; slightly more distal are elements for
weak general epidermal expression and stronger general
CNS expression; and, in a region more distal to the gcm
promoter between 4.9 and 1.4 kb lie elements that
promote gcm-independent CNS glial-specific activity, as
well as repressing general neuronal activity.
Fig. 2. h-gal expression of gcm-lacZ reporter genes: 5Vproximal region constructs. gcm 4.9 transgenes recapitulate many elements of gcm expression. gcm
1.4 transgenes show general neural expression. (A) Genomic map and reporter constructs. (B–J) Whole-mount transgenic embryos labeled with anti-h-gal
(anterior to left). (B,C) Ventral views of gcm 1.4-gcmp-lacZ embryos at stage 12 (B) and stage 13 (C) show general neural expression, strongest in the lateral
CNS. (D–J) gcm 4.9-hs43-lacZ embryos. (D) Stage 9, lateral view. Arrowhead indicates expression in head mesoderm/hemocyte primordium. (E, G, I) Stage
13 embryos. (F, H, J) stage 16 embryos. (E, F) Lateral views, focused on CNS, show glial expression. (G, H) Lateral views, focused on epidermis, show
expression in epidermal stripes (arrows). (I, J) ventral views show expression in CNS-derived glia, including peripheral glia (PG) and longitudinal glia (LG).
Scale bar, 50 Am.
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glial expression and macrophage expression
Reporter constructs with genomic DNA between 8.9
and 4.4 kb—further distal to the gcm promoter—drive
strong CNS glial-specific expression and strong hemocyte
expression. In gcm 8.9/4.4-hs-43 embryos, h-gal isexpressed strongly in hemocytes as they develop into
macrophages (Fig 4A, arrowhead); expression persists in
macrophages in subsequent stages (Figs. 4B–E). In gcm
8.9/4.4-hs-43 embryos, h-gal expression in CNS-glia
can first be seen at stage 11 (Fig 4B, arrow), and persists
through later stages (Figs. 4B–E). gcm 7.4/4.4-hs-43
reporters, deleting the distal part of the 8.9-kb region
Fig. 3. gcm 4.9 transgene expression is not dependent on gcm. Dissected stage 16 embryos showing seven adjacent segments of the CNS labeled with anti-h-
gal (anterior up). (A) gcm 4.9 transgenic embryos show h-gal expression in CNS-derived glia. (B) gcm 4.9; gcm null mutant embryos: h-gal labels specific
neurons. In gcm mutant embryos, expression is initiated in the CNS in presumptive glia that are transformed into neurons. Scale bar, 10 Am.
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two GBSs), showed identical staining to 8.9/4.4-hs-43
embryos (data not shown). Constructs of both fragments
using gcmp-lacZ vector showed similar expression pat-
terns, but with much stronger and earlier hemocyte-
specific expression (data not shown), suggesting that there
is synergy between early hemocyte elements proximal to
the promoter and late hemocyte/macrophage-specific ele-
ments in the 7.4 to 4.4 kb region; in addition, these
lines show epidermal staining associated with the gcmp-
lacZ vector.
When gcm 8.9/4.4 and gcm 7.4/4.4 reporters
are crossed into a gcm null background, all CNS
expression disappears (Figs. 4G–I); unlike gcm 4.9,
there is no staining in CNS neurons, indicating that gcm
is required for initiating CNS expression in these report-
ers. Hemocyte/macrophage expression persists in gcm
mutant embryos, revealing the existence of a gcm-inde-
pendent hemocyte enhancer in the 7.4 kb to 4.4 kb
region. The presence of two high-affinity GBSs and as
many as three lower-affinity GBSs in the 7.4 to 4.4
sequence suggests that Gcm directly regulates glial-spe-
cific expression from this region. We conclude that the
region between 7.4 and 4.4 kb contains both gcm
autoregulatory elements and gcm-independent hemocyte
elements.Identification of GB 6–4A element in the gcm 3Vregion
We initially tested a 3.9-kb fragment 3Vof gcm for
activity using the hs43-lacZ vector (gcm +1.7/+5.6, Fig.
5A); we found no activity from this fragment. However,
after realizing that it contained the promoter region of
the adjacent gene CG4389, we cut back this element to
+4.5, and found that it drives h-gal expression in a
subset of abdominal glia, and maxillary glia (Figs. 5B–
C). Using several overlapping constructs (Fig. 5A), we
narrowed this activity down to a 742-bp fragment that is
located midway between gcm and its neighboring 3Vgene
(from +3777 to +4519 relative to the gcm promoter). We
also cloned the original fragment (which did not show
expression in the hs43-lacZ vector) into the gcmp-lacZ
vector. gcm+1.7/+5.6-gcmp-lacZ embryos show h-gal
expression in the same subset of glia as the other
fragments from this region; in addition, these embryos
show early hemocyte expression and epidermal expres-
sion associated with gcmp-lacZ (Table 1, data not
shown). We conclude that enhancer activity in the gcm
+1.7/+5.6 fragment can work preferentially on the gcm
promoter.
Expression from a reporter line showing this glial-
specific activity is depicted in Fig. 5. h-gal is first
detected at stage 11 in a single neural precursor in each
Fig. 4. gcm-dependent glia expression elements and hemocyte elements in 5Vdistal region constructs. (A–E) Whole-mount gcm 8.4/4.4hs43 lacZ
embryos labeled with anti-h-gal (anterior to left). (A) Stage 10, lateral view. Arrowhead indicates hemocyte expression. (B) Stage 11, lateral view. Glial
precursor expression (arrow). (C) Stage 14, lateral view, shows CNS-derived glial expression (arrow). (D) Stage 16, lateral view and (E) ventral view.
Expression persists in all CNS-derived glia (arrows) and hemocytes. (F) Genomic map and reporter constructs. (G– I) gcm 8.4/4.4; gcm null mutant
embryos; same stages and views as (C–E). In gcm mutant embryos, expression is not initiated in the CNS; they lack glial and CNS expression, but retain
hemocyte expression. Scale bar, 50 Am.
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through 7, and in a similar neural precursor in the
maxillary segment (Figs. 5B and 6A,C). We identify this
precursor in abdominal segments as GB 6–4A, by posi-
tion, colabeling with Engrailed and Repo (data not
shown), and by its glial progeny. 6–4A is a pure glioblast
that is positioned as the most anterior and lateral En-
grailed expressing cell in the neuroblasts array, which
divides once to give rise to two glia—the most-medial
cell body glia (MM-CBG) and the medial cell body glia
(M-CBG) (Broadus et al., 1995; Ito et al., 1995; Schmidtet al., 1997). Expression driven by the gcm 3Venhancer
element follows this pattern, and is specific to the 6–4A
lineage (Figs. 5B–F).
The homeotic gene abdominal-A is required for expression
of the gb 6–4A element
The homeotic gene abdominal-A (abd-A) is expressed
in the abdominal segments from the posterior Engrailed
stripe of A1 through A7 (Macias et al., 1990; Karch et al.,
1990) and is required for abdominal segment identity
Fig. 5. Abdominal CNS glioblast-specific enhancer located 3Vof gcm. (A) Genomic map and reporter constructs. Constructs with no activity are designated
‘‘n.a.’’, and constructs with identical activity are designated with a red plus symbol. (C–F) Whole-mount gcm+1.7/+4.5-hs43-lacZ embryos labeled with anti-
h-gal (anterior to left). Expression first appears at late stage 10 (B) in GB 6-4A, and in a similar precursor in the maxillary segment, as they begin to divide to
give rise to abdominal glia M-CBG and MM-CBG and a pair of maxillary glia. (C, D) Stage 14, lateral (C) and ventral (D) views. (E, F) Stage 16, lateral (E)
and ventral (F) views. mx, maxillary segment; a1, abdominal segment 1; a7, abdominal segment 7. Scale bar, 50 Am.
B.W. Jones et al. / Developmental Biology 266 (2004) 374–387 383(Sanchez-Herrero et al., 1985). Since the gcm 3Velement is
expressed in the GB 6–4A lineage in A1 through A7 in
the same domain as abd-A, we decided to test if abd-A is
required for this expression. We found that abd-A mutantFig. 6. Expression of 3Venhancer in GB 6–4A requires the homeotic gene abd-A
left) (A, C) gcm +1.7/+4.5-hs43-lacZ embryos, lateral view (A), and ventral view
view (B), and ventral view. In abd-A mutant embryos, expression in the GB 6
maintained. mx, maxillary segment; a1, abdominal segment 1; a7, abdominal segembryos carrying the gcm +1.7/+4.5 reporter show a
complete loss of h-gal expression in abdominal segments,
while maintaining expression in the maxillary segment
(Figs. 6B,D).. Whole-mount embryos at late stage 10 labeled with anti-h-gal (anterior to
(C). (B, D) gcm +1.7/+4.5-hs43-lacZ; abd-A null mutant embryos, lateral
–4A lineage is lost, while expression in the maxillary segment lineage is
ment 7. Scale bar, 50 Am.
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We have completed a survey of the gcm locus for cis-
regulatory enhancer activity using lacZ reporter fusion
genes in vivo, and have mapped DNA regions that promote
most of the elements of the gcm expression pattern (sum-
marized in Fig. 7). These elements can be separated into
distinct modules that reveal the logic underlying the tran-
scriptional regulation of gcm. During development, gcm is
primarily expressed in two separate tissues: neuroectoderm-
derived glial cells and mesoderm-derived hemocytes. Ex-
pression in these tissues appears to require both general
control elements and lineage-specific control elements.
Close to the gcm promoter are weak and broadly expressed
tissue-specific control elements, while more distant from the
promoter lie lineage-specific control elements.
In the case of hemocyte expression, we find two distinct
regions that promote expression in early and late phases of
hemocyte development, respectively. Close to the gcm
promoter (between 0.2 kb and the transcription start site)
are sequences that promote the early, germ-layer phase of
gcm expression in the procephalic mesoderm domain that
comprises the hemocyte primordium. Expression in this
procephalic mesoderm domain is weak and transient. Based
on the timing and position of expression, activity driven by
this early element likely depends on position-specific cues
that pattern the blastoderm along the dorsal–ventral and
anterior–posterior axis. More distal to the promoter, be-
tween 7.4 and 4.4 kb, are sequences that promote later
hemocyte lineage-specific expression. Based on the timing
and specificity of this expression, activity driven by this late
element is likely dependent on factors already expressed in
the hemocyte lineage. Reporter constructs that carry both
elements act synergistically to produce more robust hemo-
cyte expression.
In the case of glial cell expression, we find at least three
different components promoting activity: a general neural
component, a lineage-specific component, and an autore-
gulatory component. Close to the gcm promoter (between
1.4 and 0.2 kb) are sequences that promote broad, but
weak, pan-neural expression. More distal to the promoter,
as well as downstream of the gcm transcription unit, are
lineage-specific elements. It appears that most of the
activity required to initiate expression in CNS glial lineages
is in the distal 3-kb portion of the first 5 kb (between 4.4Fig. 7. Summary: DNA regions promoting elements of the gcm expression pattern.
restriction map, and are described in detail in the text.and 1.4) upstream of the gcm promoter. Adding this 3-kb
region to the proximal pan-neural promoting region causes
a loss of neuronal expression, indicating that, besides
promoting glial-specific expression, sequences in this ele-
ment are required to repress general neuronal activity.
These data support a model whereby glial-specific gcm
expression in the CNS requires both lineage-specific acti-
vation and general neuronal repression.
Additional lineage-specific elements are in the 3Vdown-
stream region, and, perhaps, in upstream regions as far as
18 kb from the promoter. In the 3Vregion of gcm (+3.8 to
+4.5 kb), we found an element that promotes expression in
the 6–4A glioblast lineage as well as a similar glial lineage
in the maxillary segment. These precursors generate two
glial cells in each hemisegment: the most-medial cell body
glia (MM-CBG) and the medial cell body glia (M-CBG).
Interestingly, expression is absent in the analogous precur-
sor, NGB 6–4T, found in the thoracic segments; NGB 6–
4T undergoes a slightly different pattern of divisions,
generating both neurons and glia. Here we show that
expression driven by the GB 6–4 element in the abdomen
is dependent on the homeotic gene abdominal-A, which
demonstrates that some of the segmental differences in the
specification of glial precursors along the anterior–posterior
axis are under the control of the homeotic genes of the Hox
complex; these data hold out the possibility that they do so
by directly modulating gcm expression.
None of the elements described above account for
expression in PNS glia that are derived from SOPs. Our
data suggests that expression in SOP-derived glia may be
driven by other enhancer elements, and we speculate that
they may be in a region as distant as 18 kb from the
promoter, as several of our reporter constructs from the
region midway between gcm and gcm2 show weak expres-
sion in SOP-derived glia (data not shown). Whether these
are bona fide enhancer elements of gcm is not clear, as
different transgenic lines show much variability in expres-
sion driven from these constructs. It is possible that addi-
tional gcm proximal promoter sequences are required to
enable a strong response from these distant enhancer
elements. In a study of the large and complex regulatory
region of the mitotic regulator encoded by the string locus,
it was found that promoter proximal sequences as far away
as 525 base pairs from the transcription start site are
required to allow a response specifically from distantRegions promoting specific activities are shown as colored bars beneath the
B.W. Jones et al. / Developmental Biology 266 (2004) 374–387 385enhancers (Lehman et al., 1999). Alternatively, SOP-de-
rived glia expression may require the synergistic or additive
interaction between multiple elements that are in separate
regions.
The third component contributing to gcm glial expression
is autoregulation. Previous studies implicate a positive
autoregulatory feedback mechanism in gcm transcriptional
regulation (Miller et al., 1998). These studies showed that
gcm transcription is initiated, but not maintained, in a
mutant allele (gcmN7-4) that carries a point mutation in the
DNA binding domain. This point mutation creates an amino
acid change that abolishes the ability of Gcm protein to bind
DNA in vitro. In addition, ectopic expression of gcm is able
to induce ectopic h-gal in a gcm enhancer trap line. This
evidence, and the presence of multiple Gcm protein binding
sites (GBSs) in the 5V region of gcm, implicates direct
autoregulation of gcm. In support of these observations, we
describe elements that drive gcm-dependent glial cell ex-
pression; these elements are located further distal (7.4 to
4.4 kb) to the region that initiates gcm-independent glia
cell expression, and the sequence contains two high-affinity
GBSs and as many as three or more lower-affinity GBSs.
Interestingly, hemocyte lineage-specific elements that are
also found in this region are not dependent on gcm for their
expression, suggesting that autoregulation is also context
dependent and may require the cooperation of additional
factors.
Our expression data using gcm-lacZ reporter gene
fusions agree with a recently published study that used
genomic transgenes to rescue gcm mutant phenotypes
(Ragone et al., 2003). These genomic rescue experiments
used four constructs, containing the gcm coding sequences,
1.7 kb of downstream, and 2, 4, 6, and 9 kb of upstream
sequences, respectively. They showed that the 4-kb up-
stream transgene was able to rescue glial cell differentiation
in most CNS glial lineages; however, the ability to rescue
was not fully penetrant, and required additional upstream
DNA to provide ‘‘quantitative’’ elements. Full rescue in
nearly all CNS glial lineages was only achieved with 9 kb of
upstream DNA. These data, together with our studies,
suggest that this quantitative regulation is provided by
gcm autoregulatory elements. Interestingly, the genomic
rescue transgenes gave very poor rescue of the 6–4 line-
ages, and we observe that they also lack the 3V6–4A
regulatory elements identified in our study. A comparison
of these two studies suggests there are as yet unidentified
elements required for high levels of gcm expression in the
NGB 6–4T lineage. Another interesting comparison be-
tween these two studies is the rescue provided by the 2-kb
genomic transgene vs. the expression driven by our gcm
1.4 reporter construct. In the genomic rescue studies, the
2-kb upstream transgene rescued glial differentiation in a
defined subset of CNS glial lineages, but also showed
precocious gcm expression and glial transformation of
several nongliogenic neuroblasts. Our gcm 1.4 reporter
construct, which differs in length from the 2-kb genomictransgene by 740 base pairs, shows broad low-level neural
expression. Taken together, we conclude that there are CNS
lineage-specific elements in the 740 base pair region that
differs between these two constructs, as well as a require-
ment for neuronal repression provided by elements distal to
this region.
While our study was not directed toward understanding
the regulation of the gcm homolog, gcm2, it is interesting to
note that we did not find any glial-specific or hemocyte-
specific enhancer activity proximal to the gcm2 promoter.
gcm2 is expressed at very low levels in glial cells and at
more pronounced levels in developing hemocytes (Alfonso
and Jones, 2002; Kammerer and Giangrande, 2001).
Reflecting this expression pattern, the role of gcm2 in glial
cell development is very minor, while it has more significant
role in hemocyte development (Alfonso and Jones, 2002).
Our data indicates, as previously suggested by Kammerer
and Giangrande, 2001, that gcm2 derives its expression
pattern from enhancer elements shared with gcm and/or
direct regulation by gcm.
gcm occupies the most upstream position in lateral glial
cell determination. It follows that gcm is regulated by a
combination of factors not specific to glia. Candidates
include a variety of transcriptional regulators expressed in
the neuroectoderm, GBs, NGBs, ganglion mother cells,
SOPs, and their progeny. Thus, the regulation of gcm
provides a model for understanding how these factors
combine to give rise to stereotypic patterns of glial vs.
neuronal progeny. One model for gcm transcription is that
its regulatory DNA is modular, where each module integra-
tes a combination of inputs to activate gcm in different
lineages. At one extreme, each glial lineage and glial
subtype possibly have separate regulatory modules with
unique modes of regulation. Alternatively, gcm may have
a limited number of regulatory elements that respond to
signals present in multiple developmental environments.
Our results indicate that gcm regulation is controlled by a
combination of general and lineage-specific elements. We
have found one lineage-specific element that is expressed in
a single neural precursor (GB 6–4A), indicating that at least
one neural precursor lineage has a unique mode of regula-
tion. In principle, a fine dissection of the 3-kb region that
promotes most CNS glial cell expression will possibly
reveal additional neural precursor specific elements, as is
suggested by the genomic rescue data.
The comparison of regulatory regions between related
species has been shown to be a powerful tool to identify
important evolutionary conserved cis-regulatory DNA
sequences. Comparison of the gcm locus in D. mela-
nogaster to the recently released sequence of a sibling
Drosophila species, D. pseudoobscura, shows the gcm
locus to be highly conserved, both with respect to gene
order and distances between genes. There is high degree
of intermittent sequence similarity in the 9 kb upstream of
gcm in both species, and the gaps of dissimilarity may
serve as a guide to further identify the boundaries of
B.W. Jones et al. / Developmental Biology 266 (2004) 374–387386specific cis-regulatory sequences. When we compare the
3V downstream region of gcm in both species, we find
that the only significantly conserved sequence is located
within the 742 base pair fragment that we identified by
our gcm-lacZ reporter analysis as the GB 6–4A enhancer;
this sequence similarity consists of a continuous stretch of
approximately 500 base pairs that is 80% conserved,
which confirms the predictive value of interspecies se-
quence comparisons.
We also note that in the first 5 kb of upstream gcm
sequence in both species are five highly conserved
consensus Suppressor of Hairless [Su(H)] binding sites
(Bailey and Posakony, 1995). Su(H) is the primary
effector of the Notch signaling pathway (reviewed by
Artavanis-Tsakonas et al., 1999). Four of these Su(H)
sites are clustered in the 3-kb region (4.4 to 1.4 kb)
that promotes most CNS gliogenesis. Notch signaling has
been shown to influence gcm transcription and glial cell
differentiation in binary cell fate decisions, with the
general rule that it promotes gliogenesis in the case of
neuronal/glial sibling pairs, but has the opposite effect on
secondary precursor/sibling pairs (Udolph et al., 2001;
Umesono et al., 2002; Van De Bor and Giangrande,
2001). The presence of Su(H) binding sites suggests that
Notch-mediated regulation may be directly influencing
gcm transcription, and future analysis may provide an
opportunity to dissect the context-dependent utilization of
Notch signaling in glial cell differentiation.
In summary, we have performed a systematic charac-
terization of the cis-regulatory regions controlling gcm
transcription by reporter gene fusions. These studies rep-
resent a first step in elucidating how a diverse set of
positional, temporal, and lineage-specific factors are inte-
grated at the gcm promoter to produce a complex pattern
of expression in a precise and stereotypic manner during
neural development and hematopoiesis.Acknowledgments
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